The agreement will give SOTAX distribution rights to Waters ACQUITY UPLC H-Class System within small molecule pharmaceutical accounts
Waters Corporation has entered into an agreement with the SOTAX Group, a global developer and manufacturer of equipment for dissolution testing, automated sample preparation, and physical testing of pharmaceutical dosage forms. Under the terms of the agreement, Waters will make available to SOTAX its ACQUITY UPLC H-Class System for sale to drug manufacturers performing small-molecule, solid-dosage analysis in quality control and analytical research and development.
“Improved sample preparation to keep pace with the speed of our ACQUITY UPLC instrumentation platform has often been requested by our customers,” said Mike Harrington, Senior VP – Global Markets. “This new collaboration links Waters and SOTAX technologies enabling our mutual customers to streamline their analysis, characterisation and preparation of pharma samples, and improve their productivity and profitability.”
Under the terms of the agreement, Waters licenses SOTAX as an independent distributor for the Waters ACQUITY UPLC H-Class System. SOTAX will market, sell and distribute the ACQUITY UPLC H-Class System through its own direct sales force to pharma laboratories in the following countries, the US, Canada, the UK, France, Germany, Italy, Switzerland and the Czech Republic.
“Working closely with Waters will allow us to generate significant value for our mutual customers in the current, data integrity driven environment. We are excited to have been selected by Waters to collaborate in the dissolution testing and sample preparation space,” said Patrick Ballmer, VP, SOTAX Group.
EP News Bureau
Comments are closed.